[Creation of synthetic serine proteinase inhibitors, an important pharmacological problem].
作者信息
Markwardt F
出版信息
Farmakol Toksikol. 1978 Sep-Oct;41(5):530-3.
PMID:359347
Abstract
摘要
相似文献
1
[Creation of synthetic serine proteinase inhibitors, an important pharmacological problem].[合成丝氨酸蛋白酶抑制剂的创制，一个重要的药理学问题]
Farmakol Toksikol. 1978 Sep-Oct;41(5):530-3.
2
Proteinases in cardiac and skeletal muscle.心肌和骨骼肌中的蛋白酶。
Fed Proc. 1980 Jan;39(1):20-5.
3
CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.CU - 2010——一种具有抗纤维蛋白溶解和抗凝特性的新型小分子蛋白酶抑制剂。
Anesthesiology. 2009 Jan;110(1):123-30. doi: 10.1097/ALN.0b013e318191408c.
4
[Complement inhibitors and their action mechanism].
Nihon Rinsho. 1979 May 10;37(5):977-82.
5
The multicatalytic proteinase complex.多催化蛋白酶复合体
Revis Biol Celular. 1989;20:113-23.
6
Pharmacological content of hyperproteolytic states in blood by synthetic inhibitors of serine proteinases.
Haemostasis. 1978;7(2-3):177-82. doi: 10.1159/000214259.
7
The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.丙型肝炎病毒NS3蛋白酶：一种含锌丝氨酸蛋白酶的结构与功能
Antivir Ther. 1998;3(Suppl 3):99-109.
8
Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors.
Bioorg Med Chem. 2004 Aug 1;12(15):4081-8. doi: 10.1016/j.bmc.2004.05.041.
9
[High-molecular prolylendopeptidase of human erythrocytes].
Dokl Akad Nauk SSSR. 1983;268(1):234-8.
10
Protease inhibitors in carcinogenesis: possible sites of action.
Carcinog Compr Surv. 1980;5:127-43.
Zotero 插件